Commentary: (Research Highlights Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis)

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|1|4-5

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.1, 2014-02, pp. : 4-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activation of Calpain and Caspase Pathways in Demyelination and Neurodegeneration in Animal Model of Multiple Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 313-320

Bentham Science Publishers

Access to resources Recommend Favorite

Neurodegeneration in multiple sclerosis

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 388-394

Govi-Verlag

Access to resources Recommend Favorite

Neurodegeneration and Neuroprotection in Multiple Sclerosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4471-4474

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary (Research Highlights: Utilizing Neuro-Inflammation: Turning Degeneration to Regeneration)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-01 ,pp. : 953-954

Bentham Science Publishers

Access to resources Recommend Favorite

Research Highlights: Clinical relevance of the type I interferon signature in multiple sclerosis

By Verweij Cornelis L  

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1883-1885

Future Medicine

Access to resources Recommend Favorite